Article
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.
Proceedings of the National Academy of Sciences of the United States of America - 23 Jul 2024
van Vlimmeren Anne E, Voleti Rashmi, Chartier Cassandra A, Jiang Ziyuan, Karandur Deepti, Humphries Preston A, Lo Wan-Lin, Shah Neel H
Abstract excerpt
Mutations in the tyrosine phosphatase Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2) are associated with a variety of human diseases. Most mutations in SHP2 increase its basal catalytic activity by disrupting autoinhibitory interactions between its phosphatase domain and N-terminal SH2 (phosphotyrosine recognition) domain. By contrast, some disease-associated mutations located in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
